$CYTOF

$0.07 +$0.00 (0.0%) Close

$CYTOF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.7M shares outstanding

Who owns CYTOF?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 2 holders own 23.2%

Thomas Meyer 23.2% · LRI Investments, LLC 0.0%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Altamira Therapeutics Ltd in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Altamira Therapeutics Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years100% Under 1 year0%

Quarterly turnover

0.0%

of institutional shares changed hands

Top 10 managers, median time held

2.3 years

Super Investors

Investment managers reporting CYTOF on Form 13F

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LI LRI Investments, LLC	1	0.00%	Unchanged		2024	0.0%
Shares held by quarter Peak holding1 (Q3'24) Change over 8 quarters0 Share of the company0.000% LRI Investments, LLC's full portfolio →

LRI Investments, LLC

% of company

0.00%

Change vs last qtr

Unchanged

Held since

2024

Institutional Funds

Mutual funds and ETFs reporting CYTOF on Form N-PORT; together they hold 0.0% of the company

No fund reports holding CYTOF yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TM Thomas Meyer 5%+ holder 13D · 18.9%	1.1M	23.16%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company23.160% Disclosed stake13D · 18.9% View the 13D/G filing →

Thomas Meyer

5%+ holder13D · 18.9%

1.1M

% of company

23.16%

Change vs last qtr

—

Held since

—

Comments